Log in

ACCENTMIC Accent Microcell Limited NSE · India

Accent Microcell (ACCENTMIC) news

Accent Microcell Limited is a public biotech or pharmaceutical company listed on NSE under the ticker ACCENTMIC, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Accent Microcell news

We have not published a story on Accent Microcell yet. When there is news, it will appear here.

Questions about Accent Microcell

What is the ticker symbol of Accent Microcell?

Accent Microcell Limited trades under the ticker ACCENTMIC on NSE.

Where is Accent Microcell listed?

Accent Microcell Limited is listed on NSE.

Which country or territory is Accent Microcell listed under?

Our directory records Accent Microcell Limited under India.

What does Accent Microcell do?

Our directory classifies Accent Microcell Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Accent Microcell?

The ISIN recorded for Accent Microcell Limited is INE0Q5D01013.

Does aibio.space cover Accent Microcell?

aibio.space lists Accent Microcell Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Accent Microcell?

Companies in our directory listed in the same country and business area as Accent Microcell: Bliss GVS Pharma, Sanofi India, Gufic Biosciences, Medico Remedies, Welcure Drugs and Pharmaceuticals, Wanbury.

Investor discussion: Accent Microcell

Members talk about Accent Microcell (ACCENTMIC). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:ACCENTMIC on TradingView.

Listing details

Accent Microcell Limited is a public biotech or pharmaceutical company listed on NSE under the ticker ACCENTMIC, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Accent Microcell Limited
Ticker
ACCENTMIC
Listing
NSE
Country or territory
India
Business scope
Pharmaceuticals: Major
ISIN
INE0Q5D01013
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.